logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
M

Matthew Jenner

University Hospital Southampton
H指数:37
被引数:5,060

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical, cytogenetic, and germline genetic determinants of arterial thromboembolism in IMiD-treated multiple myeloma

IMiD治疗的多发性骨髓瘤患者动脉血栓栓塞的临床、细胞遗传学和胚系遗传决定因素

Blood Cancer Journal
IF11.6
2026-09-240
OA
Sina A. Beer; David A. Cairns; Molly Went; Philip Law; Amy Holroyd; Elsa Ferris; Charlotte Pawlyn; Gordon Cook; Mark Drayson; Kevin Boyd; Faith E. Davies; Matthew Jenner; Gareth J. Morgan; Graham Jackson; Richard Houlston; Martin F. Kaiser
Induction and extended consolidation with daratumumab, cyclophosphamide, bortezomib, lenalidomide, and dexamethasone in patients with high-risk multiple myeloma (OPTIMUM/MUKnine): 5-year follow-up of a multicentre, externally controlled, phase 2 trial

达鲁珠单抗、环磷酰胺、硼替佐米、来那度胺和地塞米松诱导及延长巩固治疗高危多发性骨髓瘤患者的疗效（OPTIMUM/MUKnine研究）：一项多中心、外部对照的II期试验5年随访结果

Lancet Oncology
IF35.9
2026-09-070
OAAI
Martin F Kaiser; Rachel H Phillip; Sarah R Brown; Amy Holroyd; Elsa Ferris; Ruth M de Tute; Sadie Roberts; Laura Clayton; Kristian Bowles; Mamta Garg; Anand Lokare; Christina Messiou; Richard S Houlston; Graham Jackson; Gordon Cook; Roger G Owen; Mark T Drayson; Guy Pratt; Andrew Hall; Matthew W Jenner
NGS-based targeted sequencing guides risk-adapted and molecularly targeted therapy decisions in multiple myeloma

NGS-based靶向测序指导多发性骨髓瘤的风险适应性及分子靶向治疗决策

British Journal of Haematology
IF3.8
2025-08-260
OAAI
Gaurav Agarwal; Mohammad Kazeroun; Mirian Salazar; Khrystal McBean; Ananya Kannan; Jemma Larham; Sherin Varghese; Berrin Balik; Joseph Browning; Alexis Caulier; Y. L. Tracey Chan; Hannah Giles; Matthew Jenner; Bhuvan Kishore; Guy Pratt; Neil Rabin; Rebecca Robinson; Alexis Talbot; Zoé van de Wyngaert; Ke Xu; Sally Moore; Eileen Boyle; Naser Ansari-Pour; Karthik Ramasamy; Angela Hamblin; Anjan Thakurta; Sarah Gooding
A Novel Segmentation-Based Purity-Informed Approach Accurately Detects Total Copy Number and Its Subclonal Fraction in Myeloma Targeted Panel Sequencing Data

一种基于分割的纯度感知新方法可准确检测骨髓瘤靶向测序数据中的总拷贝数及其亚克隆分数

BLOOD
IF23.1
2024-11-050
PRE
Ansari-Pour, Naser; Kazeroun, Mohammad; Hasheminasab, Seyed Alireza; Lyon, Emma J.; Hudson-Lund, Bethan; Fitzsimons, Evie; Agarwal, Gaurav; Royle, Kara-Louise; Jenner, Matthew W.; Kaiser, Martin F.; Ramasamy, Karthik; Yong, Kwee; Boyle, Eileen M.; Gooding, Sarah; Hamblin, Angela; Thakurta, Anjan
Image quality in whole-body MRI using the MY-RADS protocol in a prospective multi-centre multiple myeloma study
INSIGHTS INTO IMAGING
IF4.5
2023-10-154
OAAI
Keaveney, Sam; Dragan, Alina; Rata, Mihaela; Blackledge, Matthew; Scurr, Erica; Winfield, Jessica M.; Shur, Joshua; Koh, Dow-Mu; Porta, Nuria; Candito, Antonio; King, Alexander; Rennie, Winston; Gaba, Suchi; Suresh, Priya; Malcolm, Paul; Davis, Amy; Nilak, Anjumara; Shah, Aarti; Gandhi, Sanjay; Albrizio, Mauro; Drury, Arnold; Pratt, Guy; Cook, Gordon; Roberts, Sadie; Jenner, Matthew; Brown, Sarah; Kaiser, Martin; Messiou, Christina
Maintenance lenalidomide in newly diagnosed transplant eligible and non-eligible myeloma patients; profiling second primary malignancies in 4358 patients treated in the Myeloma XI Trial

来那度胺在新诊断的符合移植条件和不符合移植条件的骨髓瘤患者中的维持治疗; 在骨髓瘤XI试验中治疗的4358例患者中分析第二原发性恶性肿瘤

ECLINICALMEDICINE
IF10
2023-08-015
OAAI
Jones, John R.; Cairns, David A.; Menzies, Tom; Pawlyn, Charlotte; Davies, Faith E.; Sigsworth, Rachel; Brioli, Annamaria; Jenner, Matthew W.; Kaiser, Martin F.; Olivier, Catherine; Reed, Molly; Drayson, Mark T.; Owen, Roger G.; Boyd, Kevin D.; Cook, Gordon; Morgan, Gareth J.
A phase 1b dose-escalation study of carfilzomib in combination with thalidomide and dexamethasone in patients with relapsed/refractory systemic immunoglobulin light chain amyloidosis
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
IF7.4
2023-05-227
OA
Ravichandran, Sriram; Hall, Andrew; Jenner, Matthew; Garg, Mamta; Kishore, Bhuvan; Lachmann, Helen; Gillmore, Julian; Pitchford, Alexandra; Oughton, Jamie B.; Mahmood, Shameem; Sachchithantham, Sajitha; Hawkins, Philip; Brown, Sarah; Wechalekar, Ashutosh
Implementation of Whole-Body MRI (MY-RADS) within the OPTIMUM/MUKnine multi-centre clinical trial for patients with myeloma
INSIGHTS INTO IMAGING
IF4.5
2022-07-289
OAAI
Rata, Mihaela; Blackledge, Matthew; Scurr, Erica; Winfield, Jessica; Koh, Dow-Mu; Dragan, Alina; Candito, Antonio; King, Alexander; Rennie, Winston; Gaba, Suchi; Suresh, Priya; Malcolm, Paul; Davis, Amy; Nilak, Anjumara; Shah, Aarti; Gandhi, Sanjay; Albrizio, Mauro; Drury, Arnold; Roberts, Sadie; Jenner, Matthew; Brown, Sarah; Kaiser, Martin; Messiou, Christina
Evaluation of Cardiac Repolarization in the Randomized Phase 2 Study of Intermediate- or High-Risk Smoldering Multiple Myeloma Patients Treated with Daratumumab Monotherapy
ADVANCES IN THERAPY
IF4
2021-01-203
OAAI
Chari, Ajai; Munder, Markus; Weisel, Katja; Jenner, Matthew; Bygrave, Ceri; Petrucci, Maria Teresa; Boccadoro, Mario; Cavo, Michele; van de Donk, Niels W. C. J.; Turgut, Mehmet; Demirkan, Fatih; Karadogan, Ihsan; Libby, Edward; Kleiman, Robert; Kuppens, Steven; Bandekar, Rajesh; Neff, Tobias; Heuck, Christoph; Qi, Ming; Clemens, Pamela L.; Goldschmidt, Hartmut
Autologous stem cell transplantation is safe and effective for fit, older myeloma patients: exploratory results from the Myeloma XI trial

自体干细胞移植对健康的老年骨髓瘤患者是安全有效的: 骨髓瘤XI试验的探索性结果

HAEMATOLOGICA
IF7.9
2020-12-0315
OAAI
Pawlyn, Charlotte; Cairns, David A.; Menzies, Tom; Jones, John R.; Jenner, Matthew W.; Cook, Gordon; Boyd, Kevin D.; Drayson, Mark T.; Kaiser, Martin F.; Owen, Roger G.; Gregory, Walter; Morgan, Gareth J.; Jackson, Graham H.; Davies, Faith E.
Copy number evolution and its relationship with patient outcome-an analysis of 178 matched presentation-relapse tumor pairs from the Myeloma XI trial

拷贝数演变及其与患者预后的关系-来自骨髓瘤XI试验的178匹配的表现-复发肿瘤对的分析

LEUKEMIA
IF13.4
2020-12-0126
OAAI
Croft, James; Ellis, Sidra; Sherborne, Amy L.; Sharp, Kim; Price, Amy; Jenner, Matthew W.; Drayson, Mark T.; Owen, Roger G.; Chown, Sally; Lindsay, Jindriska; Karunanithi, Kamaraj; Hunter, Hannah; Gregory, Walter M.; Davies, Faith E.; Morgan, Gareth J.; Cook, Gordon; Atanesyan, Lilit; Savola, Suvi; Cairns, David A.; Jackson, Graham; Houlston, Richard S.; Kaiser, Martin F.
Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): outcomes by prior treatment at first relapse
LEUKEMIA
IF13.4
2020-09-0741
OAAI
Dimopoulos, Meletios; Weisel, Katja; Moreau, Philippe; Anderson, Larry D., Jr.; White, Darrell; San-Miguel, Jesus; Sonneveld, Pieter; Engelhardt, Monika; Jenner, Matthew; Corso, Alessandro; Duerig, Jan; Pavic, Michel; Salomo, Morten; Casal, Eva; Srinivasan, Shankar; Yu, Xin; Nguyen, Tuong Vi; Biyukov, Tsvetan; Peluso, Teresa; Richardson, Paul
Lenalidomide before and after autologous stem cell transplantation for transplant-eligible patients of all ages in the randomized, phase III, Myeloma XI trial

在随机，III期，骨髓瘤XI试验中，所有年龄段的符合移植条件的患者进行自体干细胞移植之前和之后的来那度胺

HAEMATOLOGICA
IF7.9
2020-06-0422
OAAI
Jackson, Graham H.; Davies, Faith E.; Pawlyn, Charlotte; Cairns, David A.; Striha, Alina; Collett, Corinne; Waterhouse, Anna; Jones, John R.; Kishore, Bhuvan; Garg, Mamta; Williams, Cathy D.; Karunanithi, Kamaraj; Lindsay, Jindriska; Allotey, David; Shafeek, Salim; Jenner, Matthew W.; Cook, Gordon; Russell, Nigel H.; Kaiser, Martin F.; Drayson, Mark T.; Owen, Roger G.; Gregory, Walter M.; Morgan, Gareth J.
Real-world effectiveness and safety of ixazomib-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma

艾扎佐米-来那度胺-地塞米松在复发/难治性多发性骨髓瘤中的真实世界有效性和安全性

ANNALS OF HEMATOLOGY
IF2.4
2020-04-0137
PREAI
Terpos, Evangelos; Ramasamy, Karthik; Maouche, Nadjoua; Minarik, Jiri; Ntanasis-Stathopoulos, Ioannis; Katodritou, Eirini; Jenner, Matthew W.; Plonkova, Hana; Gavriatopoulou, Maria; Vallance, Grant D.; Pika, Tomas; Kotsopoulou, Maria; Kothari, Jaimal; Jelinek, Tomas; Kastritis, Efstathios; Aitchison, Robin; Dimopoulos, Meletios A.; Zomas, Athanasios; Hajek, Roman
Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients

通过分子谱分析预测超高危多发性骨髓瘤: 对新诊断的符合移植条件的骨髓瘤XI试验患者的分析

LEUKEMIA
IF13.4
2020-03-1131
OAAI
Shah, Vallari; Sherborne, Amy L.; Johnson, David C.; Ellis, Sidra; Price, Amy; Chowdhury, Farzana; Kendall, Jack; Jenner, Matthew W.; Drayson, Mark T.; Owen, Roger G.; Gregory, Walter M.; Morgan, Gareth J.; Davies, Faith E.; Cook, Gordon; Cairns, David A.; Houlston, Richard S.; Jackson, Graham; Kaiser, Martin F.
Daratumumab monotherapy for patients with intermediate-risk or high-risk smoldering multiple myeloma: a randomized, open-label, multicenter, phase 2 study (CENTAURUS)

Daratumumab单药治疗中危或高危阴燃性多发性骨髓瘤患者: 一项随机，开放标签，多中心，2期研究 (CENTAURUS)

LEUKEMIA
IF13.4
2020-02-0558
OAAI
Landgren, C. Ola; Chari, Ajai; Cohen, Yael C.; Spencer, Andrew; Voorhees, Peter; Estell, Jane A.; Sandhu, Irwindeep; Jenner, Matthew W.; Williams, Catherine; Cavo, Michele; van de Donk, Niels W. C. J.; Beksac, Meral; Moreau, Philippe; Goldschmidt, Hartmut; Kuppens, Steven; Bandekar, Rajesh; Clemens, Pamela L.; Neff, Tobias; Heuck, Christoph; Qi, Ming; Hofmeister, Craig C.
Response-adapted intensification with cyclophosphamide, bortezomib, and dexamethasone versus no intensification in patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial

环磷酰胺，硼替佐米和地塞米松的反应适应性强化与未强化治疗在新诊断的多发性骨髓瘤患者中的比较 (骨髓瘤XI): 一项多中心，开放标签，随机，3期试验

LANCET HAEMATOLOGY
IF17.7
2019-12-0145
OAAI
Jackson, Graham H.; Davies, Faith E.; Pawlyn, Charlotte; Cairns, David A.; Striha, Alina; Collett, Corinne; Waterhouse, Anna; Jones, John R.; Kishore, Bhuvan; Garg, Mamta; Williams, Cathy D.; Karunanithi, Kamaraj; Lindsay, Jindriska; Wilson, Jamie N.; Jenner, Matthew W.; Cook, Gordon; Kaiser, Martin F.; Drayson, Mark T.; Owen, Roger G.; Russell, Nigel H.; Gregory, Walter M.; Morgan, Gareth J.

研究方向

暂未获取到该数据
M
Martin Kaiser
H 指数:61论文数:452被引数:1.2万
F
Faith E. Davies
H 指数:98论文数:1,154被引数:4.0万
G
Gordon Cook
H 指数:80论文数:770被引数:2.2万
D
David A. Cairns
H 指数:44论文数:298被引数:7,473
G
Gareth J. Morgan
H 指数:124论文数:1,932被引数:7.1万
M
Mark T. Drayson
H 指数:77论文数:750被引数:2.3万
R
Roger G. Owen
H 指数:60论文数:543被引数:1.7万
G
Graham Jackson
H 指数:70论文数:489被引数:1.7万
C
Charlotte Pawlyn
H 指数:37论文数:263被引数:6,488
W
Walter M. Gregory
H 指数:63论文数:414被引数:1.5万